AllianceBernstein’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.7M | Buy |
1,138,022
+171,932
| +18% | +$8.12M | 0.02% | 582 |
|
|
2025
Q1 | $37.7M | Sell |
966,090
-56,514
| -6% | -$2.21M | 0.01% | 657 |
|
|
2024
Q4 | $55.4M | Buy |
1,022,604
+24,464
| +2% | +$1.32M | 0.02% | 564 |
|
|
2024
Q3 | $50.3M | Sell |
998,140
-23,610
| -2% | -$1.19M | 0.02% | 599 |
|
|
2024
Q2 | $44.9M | Buy |
1,021,750
+66,243
| +7% | +$2.91M | 0.02% | 625 |
|
|
2024
Q1 | $48M | Buy |
955,507
+46,356
| +5% | +$2.33M | 0.02% | 610 |
|
|
2023
Q4 | $54.9M | Buy |
909,151
+437,832
| +93% | +$26.4M | 0.02% | 556 |
|
|
2023
Q3 | $26.9M | Sell |
471,319
-366,440
| -44% | -$20.9M | 0.01% | 755 |
|
|
2023
Q2 | $42.7M | Buy |
+837,759
| New | +$42.7M | 0.02% | 613 |
|